Liu Tong, Zhang Qingsong, Xiao Xiaoli, Wang Yiming, Ma Xiangming, Song Mengmeng, Zhang Qi, Cao Liying, Shi Hanping
Department of Gastrointestinal Surgery/Clinical Nutrition, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing, China.
Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China.
Front Oncol. 2022 Aug 3;12:916583. doi: 10.3389/fonc.2022.916583. eCollection 2022.
Hypertension and high-salt intake may act synergistically to increase the risk of primary liver cancer (PLC). We prospectively examined the joint effect of hypertension and salt intake on the risk of PLC incidence.
A total of 92,978 participants were included in the final analyses. The study population was divided into 4 groups according to the presence or absence of hypertension and salt intake. Cox proportional hazards regression models were used to evaluate the association of hypertension and/or high-salt intake with the risk of incident cancers. The CAUSALMED procedure was used to perform the mediation analyses.
During a median follow-up of 12.69 years, a total of 418 incident cancer cases were identified. Hypertension was a risk factor for PLC in women but not in men. High salt intake was associated with an elevated risk of PLC in men. A significant interaction between salt intake and hypertension was found for the risk of PLC (P for interaction=0.045). Compared with Group 1 (hypertension-, high salt intake-), participants in Group 2 (hypertension-, high salt intake+) and Group 4 (hypertension+, high salt intake+) were associated with an elevated risk of PLC with the corresponding multivariate HRs (95%CIs) of 1.73(0.96,3.10) and 1.96(1.09,3.53) respectively. No significant mediation effect was found for the association between hypertension, salt intake and PLC risk.
The combination of high salt intake and hypertension could significantly increase the risk of PLC. It may be reasonable to recommend a low-salt intake to prevent and control the prevalence of PLC and hypertension.
Kailuan study, ChiCTR-TNRC-11001489. Registered 24 August, 2011-Retrospectively registered, https://www.chictr.org.cn/showprojen.aspx?proj=8050.
高血压和高盐摄入可能协同作用增加原发性肝癌(PLC)风险。我们前瞻性地研究了高血压和盐摄入量对PLC发病风险的联合影响。
最终分析纳入了92978名参与者。研究人群根据是否患有高血压和盐摄入量分为4组。采用Cox比例风险回归模型评估高血压和/或高盐摄入与癌症发病风险的关联。使用CAUSALMED程序进行中介分析。
在中位随访12.69年期间,共确定了418例癌症发病病例。高血压是女性PLC的危险因素,但在男性中不是。高盐摄入与男性PLC风险升高相关。发现盐摄入量与高血压之间存在显著的交互作用,影响PLC风险(交互作用P=0.045)。与第1组(无高血压、低盐摄入)相比,第2组(无高血压、高盐摄入)和第4组(有高血压、高盐摄入)的参与者患PLC的风险升高,相应的多变量HR(95%CI)分别为1.73(0.96,3.10)和1.96(1.09,3.53)。未发现高血压、盐摄入量与PLC风险之间的关联存在显著中介效应。
高盐摄入与高血压的联合作用可显著增加PLC风险。建议低盐饮食以预防和控制PLC及高血压的流行可能是合理的。
开滦研究,ChiCTR-TNRC-11001489。2011年8月24日注册 - 回顾性注册,https://www.chictr.org.cn/showprojen.aspx?proj=8050 。